PCI Biotech (Norway) Analysis
| PCIB Stock | NOK 1.40 0.10 6.67% |
PCI Biotech Holding is overvalued with Real Value of 1.25 and Hype Value of 1.4. The main objective of PCI Biotech stock analysis is to determine its intrinsic value, which is an estimate of what PCI Biotech Holding is worth, separate from its market price. There are two main types of PCI Biotech's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect PCI Biotech's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of PCI Biotech's stock to identify patterns and trends that may indicate its future price movements.
The PCI Biotech stock is traded in Norway on Oslo Stock Exchange, with the market opening at 09:00:00 and closing at 16:20:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Norway.
PCI |
PCI Stock Analysis Notes
About 32.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.44. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. PCI Biotech Holding recorded a loss per share of 2.35. The entity had not issued any dividends in recent years. The firm had 405:376 split on the 17th of September 2018. PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization technology platform. PCI Biotech Holding ASA was founded in 2000 and is headquartered in Oslo, Norway. PCI BIOTECH operates under Pharmaceuticals And Biosciences classification in Norway and is traded on Oslo Stock Exchange. It employs 11 people. To find out more about PCI Biotech Holding contact Ronny Skuggedal at (47) 67 11 54 00 or learn more at www.pcibiotech.com.PCI Biotech Holding Investment Alerts
| PCI Biotech Holding generated a negative expected return over the last 90 days | |
| PCI Biotech Holding has high historical volatility and very poor performance | |
| PCI Biotech Holding may become a speculative penny stock | |
| The company reported the revenue of 6.27 M. Net Loss for the year was (88.39 M) with profit before overhead, payroll, taxes, and interest of 6.27 M. | |
| PCI Biotech Holding has accumulated about 116.12 M in cash with (68.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.83, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 32.0% of the company outstanding shares are owned by corporate insiders |
PCI Biotech Thematic Classifications
In addition to having PCI Biotech stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | ITInformation technology and IT services |
PCI Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 81.93 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate PCI Biotech's market, we take the total number of its shares issued and multiply it by PCI Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 3rd of December, PCI Biotech holds the market risk adjusted performance of (0.93), and Variance of 48.14. In respect to fundamental indicators, the technical analysis model allows you to check helpful technical drivers of PCI Biotech, as well as the relationship between them. Please check PCI Biotech Holding treynor ratio, value at risk, and the relationship between the information ratio and maximum drawdown to decide if PCI Biotech Holding is priced fairly, providing market reflects its current price of 1.4 per share.PCI Biotech Holding Price Movement Analysis
The output start index for this execution was twenty-seven with a total number of output elements of thirty-four. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. PCI Biotech middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for PCI Biotech Holding. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
PCI Biotech Outstanding Bonds
PCI Biotech issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. PCI Biotech Holding uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most PCI bonds can be classified according to their maturity, which is the date when PCI Biotech Holding has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
PCI Biotech Predictive Daily Indicators
PCI Biotech intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of PCI Biotech stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
PCI Biotech Forecast Models
PCI Biotech's time-series forecasting models are one of many PCI Biotech's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary PCI Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About PCI Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how PCI Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling PCI shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as PCI Biotech. By using and applying PCI Stock analysis, traders can create a robust methodology for identifying PCI entry and exit points for their positions.
PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization technology platform. PCI Biotech Holding ASA was founded in 2000 and is headquartered in Oslo, Norway. PCI BIOTECH operates under Pharmaceuticals And Biosciences classification in Norway and is traded on Oslo Stock Exchange. It employs 11 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding PCI Biotech to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Dashboard Now
Portfolio DashboardPortfolio dashboard that provides centralized access to all your investments |
| All Next | Launch Module |
Other Information on Investing in PCI Stock
PCI Biotech financial ratios help investors to determine whether PCI Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PCI with respect to the benefits of owning PCI Biotech security.